ART4 and COVID-19: Of note, while CD4+ T cells from healthy donors mostly target the C terminal part of the S glycoprotein, CD4+ T cells from COVID-19 patients target almost equally both the N- and C-terminal parts of the SARS-CoV-2 S glycoprotein.